CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleLevered free cash flow is $66.42M, above the global median of $18.73M
- FinancialsAltman Z-Score 0.85: distress zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
771.43MUSDvs all stocks (USD)
Revenue (TTM)
350.47MUSDvs all stocks (USD)
Profit Margin
-23.37%Beta
0.0140xvs all stocks
52-Week Change
-3.89%vs all stocks
Market Capitalization
771.43MUSDvs all stocks (USD)
Enterprise Value
867.04MUSDvs all stocks (USD)
Forward P/E
6.26xPrice to Sales (TTM)
2.21xPrice to Book (MRQ)
39.56xEnterprise to Revenue
2.47xEnterprise to EBITDA
19.16xGross Margin
55.84%Profit Margin
-23.37%Operating Margin
16.67%Return on Assets (TTM)
2.56%Return on Equity (TTM)
-47.55%Revenue (TTM)
350.47MUSDvs all stocks (USD)
Revenue per Share (TTM)
11.51USDUpdated Jul 9, 2026Quarterly Revenue Growth
333.50%Gross Profit (TTM)
174.00MUSDvs all stocks (USD)
EBITDA (TTM)
63.35MUSDvs all stocks (USD)
Net Income (TTM)
-81.91MUSDvs all stocks (USD)
Quarterly Earnings Growth (YoY)
332.75%Operating Cash Flow (TTM)
19.01MUSDvs all stocks (USD)
Levered Free Cash Flow (TTM)
66.42MUSDvs all stocks (USD)
Trailing Annual Dividend Rate
0.00USDUpdated Jul 9, 2026Trailing Annual Dividend Yield
0.00%vs all stocks
Payout Ratio
0.00%Revenue
268.77MUSDFY2025 · Dec 31, 2025Cost of Goods Sold
141.67MUSDFY2025 · Dec 31, 2025Gross Profit
127.10MUSDFY2025 · Dec 31, 2025Operating Income
10.16MUSDvs all stocks (USD)
Pre-tax Income
-39.91MUSDFY2025 · Dec 31, 2025Income Tax Expense
28.20MUSDFY2025 · Dec 31, 2025Net Income
-68.11MUSDFY2025 · Dec 31, 2025EBIT
-9.66MUSDFY2025 · Dec 31, 2025EBITDA (Income Statement)
43.76MUSDFY2025 · Dec 31, 2025Selling, General & Administrative
99.85MUSDFY2025 · Dec 31, 2025Non-operating Interest Expense
30.25MUSDFY2025 · Dec 31, 2025Net Income from Continuing Operations
-68.11MUSDFY2025 · Dec 31, 2025Operating Cash Flow
-38.09MUSDFY2025 · Dec 31, 2025Free Cash Flow
-66.42MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
122.49MUSDFY2025 · Dec 31, 2025Income Tax Paid
1.02MUSDFY2025 · Dec 31, 2025Interest Paid
28.59MUSDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-68.11MUSDFY2025 · Dec 31, 2025Depreciation & Amortization
21.96MUSDFY2025 · Dec 31, 2025Deferred Taxes (CF)
17.81MUSDFY2025 · Dec 31, 2025Stock-based Compensation
12.95MUSDFY2025 · Dec 31, 2025Other Non-cash Items
9.21MUSDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
-6.06MUSDFY2025 · Dec 31, 2025Change in Accounts Payable (CF)
-8.72MUSDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-17.11MUSDFY2025 · Dec 31, 2025Capital Expenditures
-28.32MUSDFY2025 · Dec 31, 2025Net Acquisitions
39.36MUSDFY2025 · Dec 31, 2025Other Investing Activity
-783.65KUSDFY2025 · Dec 31, 2025Net Investing Cash Flow
10.25MUSDFY2025 · Dec 31, 2025Long-term Debt Issuance
146.04MUSDFY2025 · Dec 31, 2025Long-term Debt Payments
-127.78MUSDFY2025 · Dec 31, 2025Net Financing Cash Flow
18.26MUSDFY2025 · Dec 31, 2025Shares Outstanding
36.02MSharesUpdated Jul 9, 2026Float Shares
5.70MSharesUpdated Jul 9, 2026% Held by Insiders
33.19%vs all stocks
% Held by Institutions
7.85%vs all stocks
Total Cash (MRQ)
123.40MUSDvs all stocks (USD)
Total Cash per Share (MRQ)
2.67USDUpdated Jul 9, 2026Total Debt (MRQ)
403.70MUSDvs all stocks (USD)
Total Debt to Equity (MRQ)
1.37xCurrent Ratio (MRQ)
1.20xBook Value per Share (MRQ)
0.2850USDUpdated Jul 9, 2026Total Assets
817.15MUSDvs all stocks (USD)
Total Current Assets
305.11MUSDFY2025 · Dec 31, 2025Total Liabilities
509.73MUSDFY2025 · Dec 31, 2025Total Non-current Assets
512.04MUSDFY2025 · Dec 31, 2025Total Non-current Liabilities
318.20MUSDFY2025 · Dec 31, 2025Total Current Liabilities
191.53MUSDFY2025 · Dec 31, 2025Cash
102.23MUSDFY2025 · Dec 31, 2025Cash & Cash Equivalents
102.23MUSDFY2025 · Dec 31, 2025Other Short-term Investments
1.02MUSDFY2025 · Dec 31, 2025Accounts Receivable
12.67MUSDFY2025 · Dec 31, 2025Inventory
59.97MUSDFY2025 · Dec 31, 2025Accounts Payable
18.87MUSDFY2025 · Dec 31, 2025Short-term Debt
21.15MUSDFY2025 · Dec 31, 2025Deferred Revenue
124.68MUSDFY2025 · Dec 31, 2025Other Current Liabilities
172.81KUSDFY2025 · Dec 31, 2025Long-term Debt
282.55MUSDFY2025 · Dec 31, 2025Other Non-current Liabilities
25.43MUSDFY2025 · Dec 31, 2025Common Stock (Book)
0.00USDFY2025 · Dec 31, 2025Retained Earnings
-299.55MUSDFY2025 · Dec 31, 2025Total Shareholders' Equity
307.42MUSDvs all stocks (USD)
52-Week Low
9.70USDUpdated Jul 9, 202652-Week High
24.00USDUpdated Jul 9, 202652-Week Change
-3.89%vs all stocks
Beta
0.0140xvs all stocks
50-Day MA
12.65USDUpdated Jul 9, 2026200-Day MA
15.02USDUpdated Jul 9, 2026Avg 10-Day Volume
14.83KSharesUpdated Jul 9, 2026Avg 30-Day Volume
12.36KSharesUpdated Jul 9, 2026Diluted EPS (TTM)
-2.70USDUpdated Jul 9, 2026Other Income / Expense
-19.82MUSDFY2025 · Dec 31, 20251 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsHow does this company use capital?
Revenue Growing With Receivables Growing
Revenue has risen three years, and what customers owe has risen with it.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.56Profit Margin: -0.23
Financial Health
Altman Z-Score 0.85: distress zoneCritical
Altman Z-Score: 0.85
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Levered free cash flow is $66.42M, above the global median of $18.73MNotable
Levered free cash flow (USD): 66,416,544Global Median: 18,729,043.027
Companies that share the same coordination system — how they create, deliver, or capture value.
Heilongjiang ZBD Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Tong Ren Tang Technologies Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Teyi Pharmaceutical Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Oxford Biomedica plc
Tier 1ProductionApproval-Gated PipelineFlowRule
Luoxin Pharmaceuticals Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Keyuan Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Center Laboratories, Inc.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Chongqing Lummy Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Ginkgo Bioworks Holdings Inc.
Tier 1ProductionApproval-Gated PipelineSenseMakingInterface
Zhejiang International Group Co., Ltd.
Tier 1ProductionApproval-Gated PipelineFlow
Companies that share active interpretations — structural patterns currently present in both stocks.
Aurisco Pharmaceutical Co., Ltd.
1 interpretationRevenue Growing With Receivables Growing
Quiñenco S.A.
1 interpretationRevenue Growing With Receivables Growing
Fleury S.A.
1 interpretationRevenue Growing With Receivables Growing